Does APREPITANT Cause Hypercholesterolaemia? 159 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 159 reports of Hypercholesterolaemia have been filed in association with APREPITANT (CINVANTI). This represents 2.8% of all adverse event reports for APREPITANT.
159
Reports of Hypercholesterolaemia with APREPITANT
2.8%
of all APREPITANT reports
159
Deaths
159
Hospitalizations
How Dangerous Is Hypercholesterolaemia From APREPITANT?
Of the 159 reports, 159 (100.0%) resulted in death, 159 (100.0%) required hospitalization, and 159 (100.0%) were considered life-threatening.
Is Hypercholesterolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for APREPITANT. However, 159 reports have been filed with the FAERS database.
What Other Side Effects Does APREPITANT Cause?
Fatigue (955)
Pyrexia (913)
Dyspnoea (909)
Hypersensitivity (881)
Rash (789)
Alopecia (760)
Gastrointestinal disorder (722)
Pruritus (707)
Confusional state (696)
Glossodynia (696)
What Other Drugs Cause Hypercholesterolaemia?
ALENDRONATE (1,607)
METHOTREXATE (1,547)
TOCILIZUMAB (1,483)
ADALIMUMAB (1,479)
ABATACEPT (1,410)
RITUXIMAB (1,389)
PREDNISONE (1,377)
INFLIXIMAB (1,338)
DICLOFENAC (1,331)
LEFLUNOMIDE (1,322)
Which APREPITANT Alternatives Have Lower Hypercholesterolaemia Risk?
APREPITANT vs APROTININ
APREPITANT vs ARANESP
APREPITANT vs ARAVA
APREPITANT vs AREDIA
APREPITANT vs ARFORMOTEROL